Growth Metrics

Incyte (INCY) EPS (Basic) (2016 - 2026)

Incyte filings provide 17 years of EPS (Basic) readings, the most recent being $1.52 for Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 85.37% year-over-year to $1.52, compared with a TTM value of $7.29 through Mar 2026, up 2413.79%, and an annual FY2025 reading of $6.59, up 4018.75% over the prior year.
  • EPS (Basic) hit $1.52 in Q1 2026 for Incyte, up from $1.51 in the prior quarter.
  • The five-year high for EPS (Basic) was $2.17 in Q3 2025, with the low at -$2.04 in Q2 2024.
  • Median EPS (Basic) over the past 5 years was $0.76 (2023), compared with a mean of $0.74.
  • The largest YoY upside for EPS (Basic) was 660.0% in 2024 against a maximum downside of 324.18% in 2024.
  • Year by year, EPS (Basic) stood at $0.12 in 2022, then surged by 650.0% to $0.9 in 2023, then increased by 6.67% to $0.96 in 2024, then skyrocketed by 57.29% to $1.51 in 2025, then rose by 0.66% to $1.52 in 2026.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $1.52, $1.51, and $2.17 for Q1 2026, Q4 2025, and Q3 2025 respectively.